510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
JLJClass II

Uridine-5-Diphosphoglucose, Nad (U.V.), Alpha-D Galactose-1-Phosphate

21 CFR 862.1315 / Clinical Chemistry
FDA source (opens on fda.gov)

JLJ is the FDA product code for Uridine-5-Diphosphoglucose, Nad (U.V.), Alpha-D Galactose-1-Phosphate, a class II device type, regulated under 21 CFR 862.1315. As of , FDA records hold one 510(k) clearance under this code, the most recent dated , and one recall.

Classification record

Product code
JLJ
Device name
Uridine-5-Diphosphoglucose, Nad (U.V.), Alpha-D Galactose-1-Phosphate
Regulation
21 CFR 862.1315
Device class
Class II
Review panel
Clinical Chemistry
Submission type
510(k)
Implant
No
Life sustaining or supporting
No
GMP exempt
No
Third party review eligible
Yes
Ingested clearances
1
Ingested recalls
1

Clearances, product code JLJ

By decision year
1 clearance under product code JLJ with a decision year between 1986 and 1986, 1986 the highest year at 1.
Show the numbers
510(k) clearances under FDA product code JLJ by decision year
YearClearances
19861

Applicants with the most clearances

Product code JLJ
Applicants holding the most 510(k) clearances under product code JLJ
ApplicantClearances
Medical Specialties Inc.1

Companies listing this code with FDA

Companies whose registered establishments list this code

No registered establishment in MDM’s records lists product code JLJ.